- 1Company profiles
- 2Careers
- 3News
Monday, 19 December 2011 |
Hypertonic saline solution – the only clinically effective treatment for bronchiolitis
New ERS/ISAM* consensus statement on hypertonic saline solution
more
Monday, 02 May 2011 |
Inhalation devices for Japan
PARI donates mobile inhalation devices for Japanese earthquake and tsunami victims
more
Monday, 04 April 2011 |
Advancing the pulmonary specialist’s knowledge of inhalation therapies
A new European Consensus Paper helps specialists choose the best delivery system as there are a vast number of technical solutions on the market for efficient inhaled drug therapy
more
Tuesday, 22 March 2011 |
More time for an effect: With the PARI SINUS an aerosolized substance resides longer at the site of action
Data from a recent study suggest that compared to a nasal spray, the aerosol delivered by the PARI SINUS reached the parasnasal cavity with a longer residence time and may contribute to more efficient therapy.
more
Monday, 14 February 2011 |
Comparison study: none of the 18 disposable nebulisers tested performed to PARI’s quality and standards
Disposable devices commonly used in France are not suitable alternatives for PARI nebulisers!
more
Monday, 14 February 2011 |
Experience from daily routine of a pulmonologist: Nebulisers led to better disease control in his difficult cases of asthma or COPD
Dr. Marcus successfully switched adult patients with poorly controlled symptoms from metered dose or dry powder inhalers to nebulisers.
more
Thursday, 02 December 2010 |
Nebulised antibiotic: decreased exacerbations and better quality of life for patients with bronchiectasis
The largest long-term study on an inhaled antibiotic to date demonstrated that the therapy helps patients in multiple ways
more
Tuesday, 23 November 2010 |
Pilot study with MucoClear 6% in bronchiectasis: 12% of patients find improvements "life-changing“
Current study with 41 patients was presented during the annual congress of the European Respiratory Society
more
Tuesday, 23 November 2010 |
Patients with bronchiectasis judge nebulised hypertonic saline as very useful
How useful are the different therapies to patients with bronchiectasis? A group of British physicians asked that patient-centered question to 36 of their bronchiectasis patients. They were interested in knowing patients’...
more
Wednesday, 24 November 2010 |
Sopranos find: Nebulised saline makes singing more effortless
The influence of dry vocal cords on the intonation effort was investigated in 34 professional singers.
more
Wednesday, 15 September 2010 |
PARI welcomes you at the ERS congress 18 - 22 September 2010 in Barcelona
The European Respiratory Society's congress is the largest annual scientific gathering in respiratory medicine in the world.
more
Thursday, 05 August 2010 |
Cystic fibrosis: Does hypertonic saline improve nutritional status?
Results were presented at this year’s European Cystic Fibrosis Conference from a study in which BMI had significantly increased for 14 cystic fibrosis patients after inhaling hypertonic saline for at least 18 months.
more
Monday, 19 July 2010 |
PARI SINUS and dornase alfa: an efficient tandem team in treating chronic rhinosinusitis
Chronic rhinosinusitis is a complex condition that is quite common and considerably compromises the quality of life in cystic fibrosis patients. In a study conducted with the mucolytic drug dornase alfa via PARI SINUS, cystic...
more
Monday, 21 June 2010 |
PARI LC SPRINT: nebuliser of choice for clinical trials with inhaled antibiotic
The main advantage of inhaled antibiotic therapy is that the drug directly reaches the site of action and reduces adverse events for the entire organism. Recent results from ongoing clinical trials with ciprofloxacin – an...
more
Monday, 21 June 2010 |
Comparison of four portable jet nebuliser systems: PARI BOY® mobile S performed best
In vitro tests revealed significant advantages of the lightweight PARI BOY® mobile S. Compared to the other systems, PARI BOY® mobile S produced more respirable droplets for inhalation into the deep lungs and nebulised the test...
more
Wednesday, 16 June 2010 |
See the PARI SINUS in action at the ECFC!
The nasopharyngeal cavity is of particular concern for CF patients as a possible portal of entry for pathogens. This is why a therapy with the PARI SINUS is of special importance!
more
Wednesday, 28 April 2010 |
MucoClear 3% - a mild, hypertonic inhalation solution for mobilisation of secretions in patients suffering from bronchiolitis and cystic fibrosis
With MucoClear 3%, PARI GmbH has added a further product to its portfolio of saline solutions, in this case a three-percent hypertonic saline solution for mobilising secretion. MucoClear 3% is the first three-percent hypertonic...
more
Monday, 26 April 2010 |
Full steam ahead into the paranasal sinuses – PARI SINUS in action
In an imaging study conducted with 15 healthy volunteers, Dr Moeller and his team succeeded in showing that the paranasal sinuses cannot be reached by inhalation from nasal sprays as opposed to inhalation with the PARI vibrating...
more
Saturday, 20 February 2010 |
Olympia 2010 in Vancouver
This year again, PARI has been named the official supplier to the German Olympic team in Vancouver 2010
more
Wednesday, 10 February 2010 |
Now available: Videos demonstrating the use of PARI products
Pictures say more than a thousand words – and moving images are even better!
more
Wednesday, 18 November 2009 |
Inhaling saline reduces the risk of infection
Whenever we speak or cough, we all exhale tiny droplets of fluid, technically known as bioaerosols. These bioaerosols may carry a wide range of germs that are responsible for the spread of flu, TB and many other infectious...
more
Wednesday, 14 October 2009 |
The PARI BOY® – a Brand of the Century
The PARI BOY® is honoured as one of the "Brands of the Century" in the latest issue of the book with the same name from the "Deutsche Standards" series. The prize, which takes the form of an ornamental column made of porcelain,...
more
Tuesday, 29 September 2009 |
Independent network of scientists confirms the efficacy of hypertonic saline for cystic fibrosis
Cystic fibrosis patients produce mucus in their airways that is difficult to clear. This often leads to infections and damage to the lungs.
more
Tuesday, 29 September 2009 |
Expert Opinion: Holding Chambers for patients of all ages
Two Italian physicians reported in the scientific journal “Expert Opinion on Drug Delivery” on their experiences in inhalation therapy [1]. Their policy in daily practice is to use holding chambers together with asthma inhalers...
more
Wednesday, 16 September 2009 |
PARI granted US patent for its VORTEX® holding chamber
PARI Respiratory Equipment, the Midlothian-based US subsidiary of the PARI Group, which has its headquarters in Starnberg, Germany, has been granted a US patent for its VORTEX® antistatic holding chamber with two-way valve system.
more
Wednesday, 01 July 2009 |
PARI on the Internet: fresh and functional with a new website
www.pari.de: PARI is launching a new website on the world wide web, offering medical professionals and patients solutions that are both fresh and functional for all issues concerning inhalation and respiratory tract health.
more
Thursday, 18 June 2009 |
Dry airways – are they a major factor in diseases of the respiratory tract?
A German-American research group used a transgenic mouse model to demonstrate that osmotic regulation disorders of the pulmonary epithelial cells bring about partial dehydration of the liquid film on the surface of the...
more
